Do regulatory agencies accept steady-state equivalence studies? [Design Issues]

posted by libaiyi – China, 2024-12-04 09:34 (553 d 01:12 ago) – Posting: # 24307
Views: 9,273

Dear friend,

I am currently conducting a single-dose bioequivalence study, but it is difficult to achieve equivalence due to high variability. I am wondering if it is possible to design a steady-state bioequivalence study, but I don't know if regulatory agencies accept steady-state BE studies like this, if there have been successful precedents for such a design, and what the conditions for its application are. Many thanks.


Libaiyi

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
206 visitors (0 registered, 206 guests [including 18 identified bots]).
Forum time: 11:47 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5